2 unchanged sentences
We invest in corporate bonds, commercial paper, asset-backed securities and U.S.
−Removed: Treasury and other government agency notes, which are reported at fair value.
+Added: Treasury and other government agency notes for purposes other than trading which are reported at fair value.
These securities are subject to interest rate risk and credit risk.
5 unchanged sentences
See Note 11, Debt , to our consolidated financial statements included herein for further discussion of our 2025 Notes, which bears interest at a fixed rate.
−Removed: At December 31, 2022, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6 million of principal remains outstanding on the 2024 Notes.
−Removed: As a result of the Flexion Acquisition and as discussed in more detail in Note 11, Debt , to our consolidated financial statements included herein, any future conversion rights for the 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the 2024 Notes.
−Removed: Upon issuance, the Term Loan provided for a single-advance term loan in the principal amount of $375.0 million and is scheduled to mature on December 7, 2026.
−Removed: Each term loan borrowing which is an alternate base rate borrowing bears interest at a variable rate per annum equal to the Alternate Base Rate (as defined in the Credit Agreement) subject to a 1.75% floor, plus 6.00%.
−Removed: Each term loan borrowing which is a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR rate (as defined in the Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%.
−Removed: At December 31, 2022, we had $296.9 million in outstanding borrowings under the Term Loan.
−Removed: A hypothetical 100 basis point increase in interest rates would have increased interest expense during the year ended December 31, 2022 by approximately $3.6 million.
+Added: At December 31, 2023, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6 million of principal remains outstanding on the Flexion 2024 Notes.
+Added: As a result of the Flexion Acquisition and as discussed in more detail in Note 11, Debt , to our consolidated financial statements included herein, any future conversion rights for the Flexion 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the Flexion 2024 Notes.
+Added: The TLA Term Loan provides for a single-advance term loan in the principal amount of $150.0 million and is scheduled to mature on March 31, 2028.
+Added: Each term loan borrowing that is a term benchmark borrowing or daily simple SOFR borrowing bears interest at a rate per annum equal to (i) the Adjusted Term SOFR Rate or Adjusted Daily Simple SOFR (as each is defined in the TLA Credit Agreement), plus (ii) a spread based on our Senior Secured Net Leverage Ratio ranging from 3.00% to 3.75%.
+Added: At December 31, 2023, the outstanding principal on the TLA Term Loan was $116.6 million.
+Added: As of December 31, 2023, borrowings under the TLA Term Loan consisted entirely of term benchmark borrowings at a rate of 8.46%.
+Added: Pacira BioSciences, Inc.
+Added: | 2023 Form 10-K | Page 84
+Added: Table of Content s
+Added: hypothetical 100 basis point increase in interest rates would increase interest expense over the next 12 months by approximately $1.2 million, based on the balances outstanding for these borrowings as of December 31, 2023.
We have agreements with certain vendors and partners that operate in foreign jurisdictions.
1 unchanged sentence
Dollar, subject to an annual adjustment based on changes in currency exchange rates.
−Removed: Additionally, our accounts receivable are primarily concentrated with four large wholesalers of pharmaceutical products.
+Added: Additionally, our accounts receivable are primarily concentrated with three large wholesalers of pharmaceutical products.
In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.